We are live on
!
Find out more
Westfield Capital Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
49.45%
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17B
AUM Growth
+$1.34B
(+8.6%)
Cap. Flow
-$377M
Cap. Flow
% of AUM
-2.22%
Top 10 Holdings %
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$204M |
| 2 |
AbbVie
ABBV
|
+$141M |
| 3 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$130M |
| 4 |
Caterpillar
CAT
|
+$125M |
| 5 |
Johnson Controls International
JCI
|
+$90.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VPHM
VIROPHARMA INC
VPHM
|
+$188M |
| 2 |
Merck
MRK
|
+$155M |
| 3 |
Apple
AAPL
|
+$155M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$131M |
| 5 |
Bread Financial
BFH
|
+$96.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.01% |
| 2 | Industrials | 15.63% |
| 3 | Consumer Discretionary | 14.7% |
| 4 | Technology | 8.94% |
| 5 | Communication Services | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Lowe's Companies
LOW
$122B
| $1.69M | 0.01% |
34,195
-3,048
| -8% | -$148K |
|
252
ExxonMobil
XOM
$642B
| $1.64M | 0.01% |
16,160
-272
| -2% | -$25.1K |
|
|
TUP
253
DELISTED
Tupperware Brands Corporation
TUP
| $1.62M | 0.01% |
17,170
| – | – |
|
254
Air Products & Chemicals
APD
$66.8B
| $1.58M | 0.01% |
15,296
| – | – |
|
255
Jack Henry & Associates
JKHY
$11.2B
| $1.56M | 0.01% |
26,290
| – | – |
|
256
Sanofi
SNY
$104B
| $1.51M | 0.01% |
28,240
| – | – |
|
|
TWX
257
DELISTED
Time Warner Inc
TWX
| $1.48M | 0.01% |
22,101
| – | – |
|
258
Automatic Data Processing
ADP
$109B
| $1.47M | 0.01% |
20,701
| – | – |
|
259
Abbott
ABT
$187B
| $1.46M | 0.01% |
38,180
+10,000
| +35% | +$369K |
|
|
MJN
260
DELISTED
Mead Johnson Nutrition Company
MJN
| $1.42M | 0.01% |
16,920
| – | – |
|
261
Genuine Parts
GPC
$18.3B
| $1.38M | 0.01% |
16,580
| – | – |
|
262
American Water Works
AWK
$26.8B
| $1.36M | 0.01% |
32,300
+9,880
| +44% | +$414K |
|
263
Enviri
NVRI
$627M
| $1.36M | 0.01% |
+48,650
| New | +$1.31M |
|
264
Travel + Leisure Co
TNL
$4.74B
| $1.36M | 0.01% |
40,756
| – | – |
|
265
Kimberly-Clark
KMB
$36.1B
| $1.35M | 0.01% |
13,465
| – | – |
|
266
W.W. Grainger
GWW
$60.4B
| $1.32M | 0.01% |
5,170
+1,450
| +39% | +$377K |
|
267
PepsiCo
PEP
$189B
| $1.25M | 0.01% |
15,111
| – | – |
|
268
J.M. Smucker
SJM
$12.7B
| $1.24M | 0.01% |
11,970
| – | – |
|
|
KRFT
269
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $1.23M | 0.01% |
22,820
-3,335
| -13% | -$178K |
|
270
MetLife
MET
$64.4B
| $1.21M | 0.01% |
25,088
-8,864
| -26% | -$397K |
|
|
BCR
271
DELISTED
CR Bard Inc.
BCR
| $1.17M | 0.01% |
8,720
-315,205
| -97% | -$41.6M |
|
272
Johnson & Johnson
JNJ
$620B
| $1.15M | 0.01% |
12,500
| – | – |
|
273
GSK
GSK
$105B
| $1.1M | 0.01% |
16,416
+400
| +2% | +$25.9K |
|
274
Analog Devices
ADI
$184B
| $1.01M | 0.01% |
19,810
| – | – |
|
275
Arbor Realty Trust
ABR
$959M
| $997K | 0.01% |
149,650
| – | – |
|
Similar funds
OAG
JG
CHP
SC
Westfield Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
- Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
- Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
- Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
- Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
- Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
- Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.
Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.